Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outcome after partial frontolateral laryngectomy.

Rogério A Dedivitis1, André V Guimarães, Christiano R Guirado

  • 1Departments of Head and Neck Surgery, Hospital Ana Costa and Irmandade da Santa Casa da Misericórdia de Santos, Santos, Brazil. dedivitis.hns@uol.com.br

International Surgery
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenotoxicity of food preservatives in mammalian cells: A systematic review.

Genetics and molecular biology·2025
Same author

Mucoepidermoid microcarcinoma in the context of parotid gland cyst.

Journal of surgical case reports·2024
Same author

Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.

JAMA otolaryngology-- head & neck surgery·2023
Same author

Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.

Head & neck·2023
Same author

Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.

Frontiers in immunology·2022
Same author

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.

Frontiers in immunology·2021

Frontolateral laryngectomy shows effective long-term survival for early glottic cancer patients. This surgical approach for vocal fold carcinoma offers a high cure rate with manageable recurrence.

Area of Science:

  • Otolaryngology
  • Surgical Oncology
  • Head and Neck Cancer Research

Background:

  • Early glottic cancer requires effective treatment options.
  • Frontolateral laryngectomy is a surgical technique for laryngeal cancer.

Purpose of the Study:

  • To evaluate the recurrence rate and long-term survival after frontolateral laryngectomy for early glottic cancer.
  • To assess the efficacy of frontolateral laryngectomy in T1bN0 and T2N0 vocal fold carcinoma.

Main Methods:

  • Retrospective analysis of 30 patients with early glottic cancer treated between 1995 and 2002.
  • Surgical treatment involved frontolateral partial vertical laryngectomy with sternohyoid muscle flap reconstruction.
  • Median follow-up of 48 months.

Related Experiment Videos

Main Results:

  • 25 out of 30 patients (83.3%) survived with no evidence of disease.
  • Five patients (16.7%) experienced local recurrence.
  • Four of five recurrent cases were successfully salvaged following retreatment.
  • One disease-related death occurred.

Conclusions:

  • Frontolateral laryngectomy is an efficient and effective treatment for selected early glottic carcinoma cases.
  • The procedure offers favorable long-term survival outcomes.
  • Salvage options exist for patients experiencing recurrence.